ArticleBMJ public health2025
Implementation and fidelity of reactive surveillance and response strategies for malaria elimination: a systematic review and meta-analysis.
Article in BMJ public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Health system readiness-the neglected catalyst in Malaria elimination.Malaria journal · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: To achieve malaria elimination, case-based surveillance and response systems have been developed in endemic countries. This study systematically reviews the different types of reactive surveillance and response strategies for malaria, how they are being implemented, and their implementation fidelity, across different malaria elimination settings to inform reactive surveillance and response guidelines. Methods: A systematic review of published and grey quantitative and qualitative studies investigating different reactive surveillance and response strategies was conducted. Five databases (PubMed, Web of Science, Scopus, African Index Medicus and Latin American and Caribbean Health Sciences Literature) were searched in all years up to 16 June 2025 with no restrictions on language or publication date. Meta-analyses were performed to obtain pooled estimates of each implementation fidelity outcome of reactive surveillance and responses. Sub-group analyses of geographical regions were performed. Results: 69 studies (33 in the Asia-Pacific, including 16 in Greater Mekong Subregion, 34 in Africa and two in South America regions) were included in the review; of which 43 were included in the meta-analysis. The '1-3-7' strategy is a common reactive surveillance and response strategy developed in China and adopted by Greater Mekong Subregion countries. In Africa, many countries undertook reactive case detection alone as their reactive surveillance and response strategy (19/34 studies). In general, the implementation fidelity measured by completeness and timeliness of each step of reactive surveillance and responses was 100% in China (completeness and timeliness of case investigation: 100% (95% CI 100% to 100%) and 97% (95% CI 93% to 100%), respectively). Lowest fidelities of reactive surveillance and responses were observed in studies conducted in Africa and Greater Mekong Subregion (timeliness of case investigation: 56% (95% CI 26% to 83%) in Africa and 57% (95%CI 37% to 77%) in Greater Mekong Subregion). Conclusion: The implementation fidelity of reactive surveillance and responses varies within and across countries and regions. This may be due to differences in regional, national and sub-national health system capacity and infrastructure. Each endemic country implementing the malaria elimination programme should reevaluate, refine, improve and strengthen the ongoing strategy which is fit-for-purpose of the national health system capacity considering the global and regional evidence. Trial registration number: International prospective register of systematic reviews (PROSPERO), CRD42021249857.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.